ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov ID: NCT03978520

Public ClinicalTrials.gov record NCT03978520. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 7:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination (ABBV-599 Combination) in Subjects With Moderately to Severely Active Systemic Lupus Erythematosus

Study identification

NCT ID
NCT03978520
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie
Industry
Enrollment
341 participants

Conditions and interventions

Interventions

  • Elsubrutinib Drug
  • Placebo for elsubrutinib Drug
  • Placebo for upadacitinib Drug
  • Upadacitinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 24, 2019
Primary completion
Jan 18, 2022
Completion
Jul 13, 2022
Last update posted
Jul 20, 2023

2019 – 2022

United States locations

U.S. sites
47
U.S. states
23
U.S. cities
43
Facility City State ZIP Site status
Arizona Arthritis & Rheumatology Research, PLLC /ID# 214522 Mesa Arizona 85210-6871
AZ Arthritis and Rheumotology Research, PLLC /ID# 211329 Phoenix Arizona 85032-9306
AZ Arthritis and Rheumotology Research, PLLC /ID# 214267 Phoenix Arizona 85032-9306
Arthritis and Rheumatism Associates /ID# 211411 Jonesboro Arkansas 72401-6251
Wallace Rheumatic Studies Center, LLC /ID# 211600 Beverly Hills California 90211
Arthritis & Osteo Medical Ctr /ID# 228235 La Palma California 90623-1728
Valerius Medical Group & Research Center /ID# 211599 Los Alamitos California 90720-5402
East Bay Rheumatology Medical /ID# 211638 San Leandro California 94578
The Lundquist Institute at Harbor-UCLA Medical Center /ID# 213402 Torrance California 90502
Medvin Clinical Research /ID# 211996 Tujunga California 91042-2706
Inland Rheum Clin Trials Inc. /ID# 213617 Upland California 91786
University of Colorado Hospital /ID# 211314 Aurora Colorado 80045
Yale University /ID# 212824 New Haven Connecticut 06510
Medstar Health Research Institute /ID# 213335 Washington D.C. District of Columbia 20010
Arthritis & Rheumatic Disease Specialties /ID# 214052 Aventura Florida 33180
LeJenue Research Associates /ID# 212327 Miami Florida 33126
Ctr Arthritis & Rheumatic Dise /ID# 212326 Miami Florida 33173
Millennium Research /ID# 219099 Ormond Beach Florida 32174
IRIS Research and Development, LLC /ID# 213053 Plantation Florida 33324
West Broward Rheumatology Associates /ID# 211881 Tamarac Florida 33321
BayCare Medical Group, Inc. /ID# 218818 Tampa Florida 33614-7101
Affinity Clinical Research /ID# 211496 Oak Brook Illinois 60523-1245
Deerbrook Medical Associates /ID# 212251 Vernon Hills Illinois 60061
Qualmedica Research, LLC /ID# 214765 Evansville Indiana 47714-0805
University of Iowa Hospitals and Clinics /ID# 215246 Iowa City Iowa 52242
The Center for Rheumatology and Bone Research /ID# 211610 Wheaton Maryland 20902
Beth Israel Deaconess Medical Center /ID# 212321 Boston Massachusetts 02215-5400
Henry Ford Health System /ID# 211676 Detroit Michigan 48202
June DO, PC /ID# 211674 Lansing Michigan 48910
West County Rheumatology /ID# 225051 St Louis Missouri 63131-1703
NYU Langone Ambulatory Care Brooklyn Heights /ID# 211548 Brooklyn New York 11201
NYU Langone Orthopedic Center /ID# 213620 New York New York 10016-2772
Ohio State University - Wexner Medical Center /ID# 211636 Columbus Ohio 43210-1229
STAT Research, Inc. /ID# 211404 Vandalia Ohio 45377-9464
Premier Rheumatology of Oklahoma /ID# 213850 Tulsa Oklahoma 74136-2117
Allegheny Health Network Research Institute /ID# 211607 Pittsburgh Pennsylvania 15224
Univ TN Health Sciences Ctr /ID# 212177 Memphis Tennessee 38103
Dr. Ramesh Gupta /ID# 213381 Memphis Tennessee 38119
Tekton Research, Inc. /ID# 211521 Austin Texas 78745
Tekton Research, Inc. /ID# 214182 Austin Texas 78745
Trinity Universal Research Associates - Carrollton /ID# 211527 Carrollton Texas 75007
Accurate Clinical Management /ID# 213571 Houston Texas 77084
West Texas Clinical Research /ID# 211529 Lubbock Texas 79424
SW Rheumatology Res. LLC /ID# 211520 Mesquite Texas 75150
Carilion Clinic /ID# 213500 Roanoke Virginia 24016
Virginia Mason Medical Center /ID# 211457 Seattle Washington 98101
Rheumatology and Pulmonary Clinic /ID# 211398 Beckley West Virginia 25801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 113 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03978520, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 20, 2023 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03978520 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →